|
MAGT1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.6296300126869E-14 |
| Normal-vs-Stage2 |
2.29720000022304E-07 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
3.742000E-01 |
| Stage1-vs-Stage3 |
1.243430E-03 |
| Stage1-vs-Stage4 |
1.978350E-03 |
| Stage2-vs-Stage3 |
2.483500E-03 |
| Stage2-vs-Stage4 |
1.115520E-03 |
| Stage3-vs-Stage4 |
3.723000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.219640E-03 |
| Normal-vs-Asian |
2.2726265314077E-13 |
| Caucasian-vs-AfricanAmerican |
2.968600E-01 |
| Caucasian-vs-Asian |
9.943400E-01 |
| AfricanAmerican-vs-Asian |
3.168000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.6251444634463E-12 |
| Male-vs-Female |
2.353800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.20701235065235E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63657976059994E-12 |
| Normal-vs-Age(81-100Yrs) |
5.321700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.390600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.728610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.657000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.251200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.554200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.507800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.92372850561196E-12 |
| Classical-VS-Follicular |
3.430500E-04 |
| Classical-VS-Other |
3.002800E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.67066360745594E-12 |
| Tall-VS-Other |
6.397900E-02 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
4.802400E-02 |
| Follicular-VS-Normal |
3.96220000000724E-05 |
| Other-VS-Normal |
1.71486999999138E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.1876949664661E-11 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
2.31319999999258E-05 |
|
|
